Publication | Open Access
Rituximab as Successful Adjunct Treatment in a Patient With Disseminated Nontuberculous Mycobacterial Infection Due to Acquired Anti-Interferon- Autoantibody
87
Citations
11
References
2013
Year
ImmunodeficienciesHumoral ResponseImmunologyDrug ResistanceMedical MicrobiologySuccessful Adjunct TreatmentInfection ControlAcquired Anti-interferon- AutoantibodyAntimicrobial ResistanceHealth SciencesPulmonary TuberculosisAutoimmune DiseaseB CellsTuberculosisAutoimmunityImmunologic DiseaseClinical MicrobiologyInborn Error Of ImmunityImmune DeficiencyAutoantibody ProductionPathogenesisClinical InfectionSustained RemissionMedicine
An acquired immune deficiency due to interferon gamma (IFN-γ) autoantibodies was diagnosed in a 78-year-old Japanese man with treatment-refractory disseminated nontuberculous mycobacterial infection. In addition to standard antimycobacterial therapy, he was successfully treated with rituximab to eliminate B cells and thereby the autoantibody. Subsequently, he obtained a sustained remission from infection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1